Further work is needed to establish whether streptococcal skin infections induce intestinal damage or inflammation like colitis and whether increased IL-22 in the brain following CLN treatment is an unintended consequence of CLN therapy, causing gut dysbiosis and alterations through the bidirectional gut–brain axis. The gene discussed is IL22; the disease is colitis.